SUTENT 12.5 mg Capsule containing the lively ingredient sunitinib, respectively; It’s labeled as Antineoplastic and Immunomodulatory Brokers, Antineoplastics, Different Antineoplastic Brokers, protein kinase inhibitors and Sunitinib and is among the many licensed medicine within the Medicines and Medical Gadgets Company with the ATC code L01XE04. SUTENT 12.5 mg, which you’ll be able to receive from the pharmacy with a standard prescription, is a product of PFİZER İLAÇLARI. Transient info and prospectus paperwork for SUTENT 12.5 mg (Indications, what’s SUTENT a drug; what ought to be adopted earlier than beginning the drug, the dosage of SUTENT; whether or not its use is appropriate for many who are breastfeeding or pregnant; interplay, drawbacks; advantages, storage situations; SUTENT utilization methodology; SUTENT SUTENT 12.5 mg Capsules resembling negative effects, undesirable-side results and suggestions
The publish SUTENT 12.5 mg Capsule first appeared on İlaç Net.
